Serotonin used as prognostic marker of urological tumors

World Journal of Urology

Volumn 26, Issue 5, 2008, Pages 499-504

  Jungwirth, Nina ^a   Haeberle, Lothar ^a   Schrott, Karl Michael ^a   Wullich, Bernd ^a   Krause, Frens Steffen ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Prostate carcinoma; Renal cell carcinoma; Serotonin; Testicular cancer; Urothelial carcinoma to the urinary bladder

Indexed keywords

SEROTONIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; BLOOD; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; TESTIS TUMOR; URINARY TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; SEROTONIN; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; YOUNG ADULT;

EID: 53549121169     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-008-0285-9     Document Type: Article

References (28)

1. Schubert- Fritschle G (2005) Nachsorge oder keine Nachsorge-das ist hier die Frage. Der Urologe 44(9):991-996
2. Boonpipattanaponq T, Chewatanakornkul S (2006) Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol 40(7):592-595
3. Stapel A, Franke U, Putzki H (1992) Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers. Zentralbl Chir 117(2):77-80
4. Bertz J, Giersiepen K, Haberland J, et al (2006) Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland, Robert Koch Institut
5. Kufer R, Hautmann R (2006) Dem Nierenzellkarzinom molekularbiologisch auf den Grund gegangen. Der Urologe 45(3):295-296
6. Pottsek T (2005) Nachsorge beim Hodentumor lohnt sich. Der Urologe 44(9):1024-1030
7. Winter E (2005) Diagnostik des Hodentumors. Dtsch Ärztebl 102(44A):3021-3025
8. Erspamer V, Vialli M (1951) Presence of enteramine in the skin of Amphibia. Nature 167:1033
9. Twarog BM, Page IH (1953) Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol 175(1):157-161
10. Siddiqui EJ, Shabbir M, Mikhailidis DP et al (2006) The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation. BJU Int 97(3):634-639
11. Cunningham JL, Grimelius L, Sundin A et al (2007) Malignant ileocaecal serotonin-producing carcinoid tumours: The presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with poorer prognosis. Acta Oncol 46(6):747-756
12. Siddiqui EJ, Thompson CS, Mikhailidis DP et al (2005) The role of serotonin in tumor growth. Oncol Rep 14(6):1593-1597
13. Pyroja S, Joseph B, Paulose CS (2007) Increased 5-HT2C receptor binding in the brain stem and cerebral cortex during liver regeneration and hepatic neoplasia in rats. J Neurol Sci 254:3-8
14. Hauso O, Gustafsson BI, Loennechen JP et al (2007) Long-term effects in the rat are prevented by terguride. Regul Pept 143:39-46
15. Shuttleworth R, O'Brien J (1981) Intraplatelet serotonin and plasma 5-hydroxindoles in health and disease. Blood 57(3):505-509
16. Pawlak D, Malczy E, Darewicz J et al (2000) Platelet serotonergic mechanisms in patients with cancer of the urinary bladder. Thromb Res 98:367-374
17. Bostwick DG, Qian J, Pacelli A et al (2002) Neuroendocrine expression in node positive prostate cancer: Correlation with systemic progression and patient survival. J Urol 168(3):1204-1211
18. Dah-Shyong Y, Dar-Shih H, Hong-I C et al (2001) The expression of neuropeptides in hyperplastic and malignant prostate tissue and ist possible clinical implications. J Urol 166:871-875
19. Dizeyi N, Bjartell A, Nilsson E et al (2004) Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines. Prostate 59(3):328-336
20. de Herder WW (2007) Biochemistry of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab 21(1):33-41
21. Pinski J, Wang Q, Quek ML et al (2006) Genistein-induced neuroendocrine differentiation of prostate cancer cells. Prostate 66(11):1136-1143
22. Sommerfeld H, Partin A, Pannek J (2002) Incidence of neuroendocrine cells in the seminal vesicles and the prostate - an immunohistochemical study. Int J Urol Nephrol 34:357-360
23. Siddiqui EJ, Shabbir M, Mikhailidis DP et al (2006) The role of serotonin receptors in prostate cancer cell proliferation. J Urol 176:1648-1653
24. Autorino R, Lamendola MG, De Luca G et al (2007) Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 Patients with prostate cancer. Int J Immunopathol Pharmacol 20(4):765-770
25. Gunia S, Albrecht K, Koch S, et al (2008) Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-oberserver variability. World J Urol (online version, in print)
26. Kamiya N, Suzuki H, Kawamura K et al (2008) Neuroendocrine differentiation in stage D2 prostate cancer. Int J Urol 15(5):423-428
27. Capdevila J, Maroto P, Algaba F et al (2007) Mixed transitional cell and small cell carcinoma of the bladder with metastases with neuroendocrine histology only. Arch Esp Urol 60(3):306-309
28. Dundr P, Pesl M, Povysil C et al (2003) Large endocrine carcinoma of the urinary bladder with lymphoepithelioma-like features. Pathol Res Pract 199(8):559-563